Companies / North Carolina / Pelthos Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Pelthos Therapeutics? Who to reach and why now

Durham, North Carolina is home to Pelthos Therapeutics, a publicly listed biological products, (no diagnostic substances) company, founded 2021. It raised $18M in Nov 2025 and its filings name 9 officers. Everything below links to the record it came from.

Listed company · Biological Products, (No Diagnostic Substances) · North Carolina

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerScott PleshaSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerFrancis Knuettel IISEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerSai RangaraoSEC filing, Nov 2025Named officer in the filing; part of the buying group
Chief Technology OfficerRichard BaxterSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerPeter GreenleafSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerEzra FriedbergSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerTodd DavisSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerRichard MalamutSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerMatthew PaulsSEC filing, Nov 2025Technology and tooling decisions
For sellersWhy Pelthos Therapeutics is worth a call this quarterBuy Window: open · major agreement Oct 2026
Oct 2026Oct 2026

Corporate event

Signed a material agreement

Corporate event
Oct 30Oct 2026

New leadership

Officer or director change

New leadership
$18M

Raised

Equity raise reported to the SEC, Nov 2025. Money arrives before the spending plan does.

Capital
Track Pelthos Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Pelthos Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 30, 2026Signed a material agreementCorporate eventSEC filing
Oct 30, 2026Officer or director changeNew leadershipSEC filing
Sep 29, 2026Officer or director changeNew leadershipSEC filing
Nov 6, 2025Raised $18M in equity from 8 investorsCapitalSEC filing
Jul 1, 2025Raised $50.1M in equity from 13 investorsCapitalSEC filing

Reach Pelthos Therapeutics with emails that land

Lakewave finds the right people at Pelthos Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Pelthos Therapeutics with a free trial →

About Pelthos Therapeutics

HeadquartersDurham, North Carolina, per the filing address
Industry groupBiological Products, (No Diagnostic Substances)
Founded2021, NV
OwnershipListed company
Raise history$50.1M (Jul 2025) · $18M (Nov 2025)
Lakewave Rising32 · 2 kinds of evidence · rank in North Carolina after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Adaptin BIO · 24

Questions people ask

Did Pelthos Therapeutics raise funding in 2025?

Yes. Pelthos Therapeutics reported a $18M equity raise to the SEC on Nov 6, 2025 with 8 investors.

Who runs Pelthos Therapeutics?

The company's SEC filing, Nov 2025 names Scott Plesha (Executive Officer) among its officers.

Where is Pelthos Therapeutics headquartered?

Durham, North Carolina, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.